Assessing Synopsys (SNPS) Valuation As Ansys Integration And AI Chip Initiatives Support Growth Expectations

Synopsys (SNPS) is back in focus after American Megatrends International, Arm and Synopsys jointly unveiled an accelerated “Shift Left” initiative that moves key firmware verification into earlier RTL validation for custom silicon projects.

See our latest analysis for Synopsys.

That Shift Left announcement comes at a time when momentum in the stock has been firm, with a 90 day share price return of 19.06% and a 5 year total shareholder return of 106.31%, indicating solid long term compounding despite a more modest 1 year total shareholder return of 5.19%.

If the firmware and AI chip story has your attention, it can be useful to scan other enablers of this theme through Simply Wall St’s screener for 46 AI infrastructure stocks

With Synopsys trading around US$524.74, only about 3% below one group of analyst targets and with some models suggesting the stock trades above intrinsic value, you have to ask: is there still a buying opportunity here, or is the market already pricing in future growth?

Most Popular Narrative: 3% Undervalued

Compared with the latest closing price of $524.74, the most followed narrative pegs Synopsys' fair value at about $539.69, suggesting a small valuation gap that hinges on execution of its growth and margin plans under an 8.78% discount rate.

The acquisition and integration of Ansys positions Synopsys as the global leader in engineering solutions from silicon to systems, dramatically expanding its addressable market into sectors like automotive, industrial, and aerospace. This is expected to support long-term top-line growth as more sophisticated and complex products (especially AI-powered and smart devices) require robust simulation, analysis, and EDA tools.

Read the complete narrative.

Want to see what sits behind that confidence in revenue, earnings power and future valuation multiples? The narrative leans on ambitious growth, margin progress and a premium P/E to support that fair value, and the full breakdown joins those moving parts into one pricing story.

Result: Fair Value of $539.69 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, that upside story could be knocked off course if China related export restrictions persist, or if the Ansys integration and cost cuts prove more disruptive than expected.

Find out about the key risks to this Synopsys narrative.

Another Way To Look At It: Rich On Earnings

That fair value narrative paints Synopsys as 3% undervalued, yet the current P/E of 90.9x is far above the US Software industry at 28.4x, the peer average at 35.1x and even the fair ratio of 45.3x. This points to real valuation risk if sentiment cools.

For context on how that kind of premium can affect your margin of safety, it is worth checking how the numbers stack up in a simple earnings based breakdown, not just a story driven fair value gap. You can then decide which picture you trust more when volatility returns. See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

If this mix of confidence and caution has you thinking, now is the time to dig into the details yourself and form your own view with 1 key reward and 3 important warning signs

Looking for more investment ideas?

If Synopsys is on your radar, do not stop there. Broaden your watchlist with other opportunities so you are not relying on a single story.

• Spot potential bargains early by scanning 48 high quality undervalued stocks that pair quality fundamentals with pricing that still looks reasonable.
• Prioritize resilience by checking 69 resilient stocks with low risk scores for stocks that score well on balance sheet strength and risk metrics.
• Hunt for lesser known opportunities using the screener containing 21 high quality undiscovered gems before they attract wider attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com